Proteome Sciences' '05 Losses Widen 3.7 Percent on Shriveled Sales | GenomeWeb
This update serves to correct the reported net loss and clarify Proteome Sciences' expectation that protein biomarkers may be used to accelerate drug development and reduce costs.
NEW YORK (GenomeWeb News) - Proteome Sciences said full-year 2005 net losses increased 3.7 percent to £4.17 million ($7.7 million) from £4.02 million year over year.
The preliminary year-end report, released yesterday, also showed that total revenue slumped more than 77 percent to £16,200 from £73,000 a year ago.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Wall Street Journal reports that researchers are looking beyond Cas9 for CRISPR editing.

Familial DNA searches in criminal cases are winning over some critics, the Los Angeles Times reports.

In Nucleic Acids Research this week: ProTraits includes genetic, phenotypic data on bacteria, archaea; Candida albicans assembly 22; and more.

In PNAS this week: miR-515 levels higher in women with preeclampsia, horizontal gene transfer in parasitic plants, and more.